Amyloidosis is a multisystemic diseasecharacterized by amyloid infiltration which may involve any organ. I Isolated hypoaldosteronism and adrenal insufficiency have both been reported in patients with renal amyloidosis.v'! Both conditions are characterized by persistent hyperkalaemia and metabolic acidosis, but the biochemical abnormalities in hypoaldosteronism improve with mineralocorticoids," whereas in adrenal insufficiency, glucocorticoids are also required. Appropriate investigations to distinguish between isolated hypoaldosteronism and adrenal insufficiency, in patients with amyloidosis presenting with hyponatraemia and hyperkalaemia, are therefore essential for the proper management of these patients.
CASE HISTORY
A 79-year-old woman presented with a 3 month history of anorexia and weight loss. She had had essential hypertension for 5 years, glaucoma and a left hip replacement at age 76. Her medication included bendrofluazide 2· 5 mg daily, nifedipine 20 mg twice daily and teoptic eye drops. On examination, she was pale. Her pulse rate was 76/min and regular and blood pressure was 102170 mm Hg lying and 5010 mm Hg standing. She had hepatosplenomegaly but no ascites and rectal examination was normal. The remainder of the examination was unremarkable. Her antihypertensive medications (bendrofluazide and nifedipine) were stopped and she was admitted for investigations. Initial investigations showed: haemoglobin 15· 5 g/dL, white cell count 7·31 x lQ9/L, platelets Serum protein electrophoresis showed a diffuse increase in IgO and urine protein electrophoresis revealed the presence of lambda light chains. Bone marrow biopsy showed mainly reactive changes and a liver biopsy, to identify the cause of the hepatomegaly, revealed extensive amyloidosis.
In view of the severe postural hypotension, persistently low serum sodium concentration (range 123-134 mmol/L) and high serum potassium (range 4· 9-5' 7 mmol/L), adrenal insufficiency due to amyloidosis was suspected. However, Synacthen (tetracosactrin) stimulation test was normal (basal serum cortisol 522 nmol/L, 756 nmol/L after 30 min and 862 after 60 min) indicating normal adrenal function. Further investigations, 2 weeks after admission, revealed a recumbent plasma aldosterone concentration < 70 pmol/L (100-450 pmol/L) with plasma renin activity of <0'2 pmollml/h (1'1-2·7 pmol/ml/h) and standing plasma aldosterone concentration 110 pmol/L (200-900 pmol/L) with plasma renin activity of O' 4 pmol/ml/h (2·8-4· 5 pmol/ml/h), suggesting hyporeninaernic hypoaldosteronism. A frusemide test (40 mg frusemide orally) showed plasma renin activities of O' 2 pmol/ml/h (basal) and 0·3 pmol/ml/h (4 h after frusemide). A repeat Synacthen (tetracosactrin) stimulation test showed a basal plasma aldosterone of 80 pmol/L (100-450 pmol/L) which rose to 230 pmol/L at 30 min and 260 pmol/L at 60 min.
She was initially treated conservatively, with a high salt diet, but her serum sodium dropped to 130mmollL and serum potassium was 5·2 mmollL.
F1udrocortisone (0,05-0,1 mg/day) was introduced which resulted in an improvement in her blood pressure (130/70 mm Hg) and in her serum electrolytes (sodium 132 mmollL and potassium 4·6 mmoIlL).
DISCUSSION
Isolated hypoaldosteronism due to acquired deficiency of renin secretion by the kidney (hyporeninaemic hypoaldosteronism) was first described in 1957. 7 The condition is characterized by impaired aldosterone production in the presence of normal secretion of adrenal glucocorticoid hormones. The plasma renin activity is low and fails to rise in response to dietary sodium restriction or upright posture.! Hyporeninaemic hypoaldosteronism has been reported in many conditions which affect the kidney such as chronic pyelonephritis, gouty nephropathy, analgesic nephropathy, medullary cystic disease, hypertensive nephrosclerosis, lupus nephritis, diabetes mellitus and amyloidosis. Several mechanisms have been suggested, which include: damage to the juxtaglomerular apparatus; impaired conversion of prorenin to renin; sympathetic insufficiency; suppression of renin activity by hyperkalaemia; physiological suppression by volume expansion and alteration in synthesis of renal prostaglandins.?
Hypoaldosteronism and adrenal insufficiency have both been reported in patients with amyloidosis.v? The hypoaldosteronism may be due to infiltration of the juxtaglomerular apparatus (hyporeninaemic hypoaldosteronism)? or selective infiltration of the zona glomerulosa (hyperreninaemic hypoaldosteronismj.! Therefore, in patients with amyloidosis presenting with persistent hyponatraemia and hyperkalaemia, it is important to establish whether these abnormalities are due to hypoaldosteronism, adrenal insufficiency, or both, because the treatment is different, the first requiring mineralocorticoids and the second also requiring Ann Clin Biochem 1995: 32 glucocorticoids. In these cases, a Synacthen (tetracosactrin) test should be first performed to exclude adrenal insufficiency. If the Synacthen test is normal, further investigations to assess the renin-aldosterone axis should be done.
